000055582 001__ 55582
000055582 005__ 20240708132834.0
000055582 0247_ $$2pmid$$apmid:8615350
000055582 0247_ $$2DOI$$a10.1007/s11244-006-0114-6
000055582 0247_ $$2WOS$$aWOS:000242689200013
000055582 0247_ $$2altmetric$$aaltmetric:21816597
000055582 037__ $$aPreJuSER-55582
000055582 041__ $$aeng
000055582 082__ $$a540
000055582 084__ $$2WoS$$aChemistry, Applied
000055582 084__ $$2WoS$$aChemistry, Physical
000055582 1001_ $$0P:(DE-Juel1)VDB61599$$aSerra, J.M.$$b0$$uFZJ
000055582 245__ $$aNano-structuring in Solid Oxide Fuel Cells
000055582 260__ $$aBussum$$bBaltzer$$c2006
000055582 300__ $$a
000055582 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000055582 3367_ $$2DataCite$$aOutput Types/Journal article
000055582 3367_ $$00$$2EndNote$$aJournal Article
000055582 3367_ $$2BibTeX$$aARTICLE
000055582 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000055582 3367_ $$2DRIVER$$aarticle
000055582 440_0 $$016521$$aTopics in Catalysis$$v40$$x1022-5528$$y1
000055582 500__ $$aRecord converted from VDB: 12.11.2012
000055582 520__ $$aHealthy preterm infants fed formula with long-chain n-3 fatty acids (n-3 LCFAs) from marine oil have better early visual acuity but lower plasma phosphatidylcholine (PC) arachidonic acid (AA) and growth than infants fed formula containing linolenic acid (LLA) as the sole n-3 fatty acid. This randomized, double-blind trial was designed to study the effects of a different source of n-3 LCFAs and a shorter feeding interval on visual acuity (by Teller Acuity Card) and growth of preterm infants (n = 59; 747-1275 g birth wt), some of whom required long periods of supplemental oxygen and developed bronchopulmonary dysplasia (BPD). Infants were studied at 0, 2, 4, 6, 9, and 12 mo past term. Plasma PC AA, and normalized weight, length, and head circumference were not influenced by BPD or n-3 LCFAs except that n-3 LCFA-supplemented infants weighed less at 6 (P<0.05) and 9 (P<0.01) mo and had smaller head circumferences at 9 mo (P<0.05). Compared with control infants, however, those fed n-3 LCFAs had lower weight-for-length at 2, 6, 9, and 12 mo (P<0.0003, P<0.0114, P<0.0008, and P<0.006, respectively). n-3 LCFAs improved early (2-mo) but not later acuity among infants without BPD (P<0.02). Regardless of diet, infants with BPD had poorer grating acuity at 2 (P<0.0002) and 4 (P<0.04) mo but not thereafter.
000055582 536__ $$0G:(DE-Juel1)FUEK402$$2G:(DE-HGF)$$aRationelle Energieumwandlung$$cP12$$x0
000055582 536__ $$0G:(DE-Juel1)SOFC-20140602$$aSOFC - Solid Oxide Fuel Cell (SOFC-20140602)$$cSOFC-20140602$$fSOFC$$x1
000055582 588__ $$aDataset connected to Web of Science, Pubmed
000055582 650_2 $$2MeSH$$aArachidonic Acid: blood
000055582 650_2 $$2MeSH$$aArachidonic Acid: metabolism
000055582 650_2 $$2MeSH$$aBody Height: drug effects
000055582 650_2 $$2MeSH$$aBody Height: physiology
000055582 650_2 $$2MeSH$$aBody Weight: drug effects
000055582 650_2 $$2MeSH$$aBody Weight: physiology
000055582 650_2 $$2MeSH$$aBronchopulmonary Dysplasia: blood
000055582 650_2 $$2MeSH$$aBronchopulmonary Dysplasia: epidemiology
000055582 650_2 $$2MeSH$$aBronchopulmonary Dysplasia: physiopathology
000055582 650_2 $$2MeSH$$aDocosahexaenoic Acids: blood
000055582 650_2 $$2MeSH$$aDocosahexaenoic Acids: pharmacology
000055582 650_2 $$2MeSH$$aDouble-Blind Method
000055582 650_2 $$2MeSH$$aEnergy Intake: physiology
000055582 650_2 $$2MeSH$$aFatty Acids, Omega-3: administration & dosage
000055582 650_2 $$2MeSH$$aFatty Acids, Omega-3: pharmacology
000055582 650_2 $$2MeSH$$aFemale
000055582 650_2 $$2MeSH$$aFood, Fortified
000055582 650_2 $$2MeSH$$aHumans
000055582 650_2 $$2MeSH$$aIncidence
000055582 650_2 $$2MeSH$$aInfant, Newborn
000055582 650_2 $$2MeSH$$aInfant, Premature: blood
000055582 650_2 $$2MeSH$$aInfant, Premature: growth & development
000055582 650_2 $$2MeSH$$aInfant, Premature: physiology
000055582 650_2 $$2MeSH$$aMale
000055582 650_2 $$2MeSH$$aPhosphatidylcholines: blood
000055582 650_2 $$2MeSH$$aPhosphatidylcholines: metabolism
000055582 650_2 $$2MeSH$$aPhosphatidylethanolamines: blood
000055582 650_2 $$2MeSH$$aPhosphatidylethanolamines: metabolism
000055582 650_2 $$2MeSH$$aRegression Analysis
000055582 650_2 $$2MeSH$$aVisual Acuity: drug effects
000055582 650_2 $$2MeSH$$aVisual Acuity: physiology
000055582 650_2 $$2MeSH$$aalpha-Linolenic Acid: blood
000055582 650_2 $$2MeSH$$aalpha-Linolenic Acid: pharmacology
000055582 650_7 $$00$$2NLM Chemicals$$aFatty Acids, Omega-3
000055582 650_7 $$00$$2NLM Chemicals$$aPhosphatidylcholines
000055582 650_7 $$00$$2NLM Chemicals$$aPhosphatidylethanolamines
000055582 650_7 $$025167-62-8$$2NLM Chemicals$$aDocosahexaenoic Acids
000055582 650_7 $$0463-40-1$$2NLM Chemicals$$aalpha-Linolenic Acid
000055582 650_7 $$0506-32-1$$2NLM Chemicals$$aArachidonic Acid
000055582 650_7 $$2WoSType$$aJ
000055582 65320 $$2Author$$aSOFC
000055582 65320 $$2Author$$ananostructuring
000055582 65320 $$2Author$$aelectrocatalyst
000055582 65320 $$2Author$$acathode
000055582 65320 $$2Author$$aLSFC
000055582 7001_ $$0P:(DE-Juel1)129580$$aUhlenbruck, S.$$b1$$uFZJ
000055582 7001_ $$0P:(DE-Juel1)129637$$aMeulenberg, W. A.$$b2$$uFZJ
000055582 7001_ $$0P:(DE-Juel1)129594$$aBuchkremer, H. P.$$b3$$uFZJ
000055582 7001_ $$0P:(DE-Juel1)129666$$aStöver, D.$$b4$$uFZJ
000055582 773__ $$0PERI:(DE-600)1500978-6$$a10.1007/s11244-006-0114-6$$gVol. 40$$q40$$tTopics in catalysis$$v40$$x1022-5528$$y2006
000055582 8567_ $$uhttp://dx.doi.org/10.1007/s11244-006-0114-6
000055582 909CO $$ooai:juser.fz-juelich.de:55582$$pVDB
000055582 9131_ $$0G:(DE-Juel1)FUEK402$$bEnergie$$kP12$$lRationelle Energieumwandlung$$vRationelle Energieumwandlung$$x0
000055582 9141_ $$y2006
000055582 915__ $$0StatID:(DE-HGF)0010$$aJCR/ISI refereed
000055582 9201_ $$0I:(DE-Juel1)VDB5$$d31.12.2006$$gIWV$$kIWV-1$$lWerkstoffsynthese und Herstellungsverfahren$$x0
000055582 9201_ $$0I:(DE-82)080011_20140620$$gJARA$$kJARA-ENERGY$$lJülich-Aachen Research Alliance - Energy$$x1
000055582 970__ $$aVDB:(DE-Juel1)86642
000055582 980__ $$aVDB
000055582 980__ $$aConvertedRecord
000055582 980__ $$ajournal
000055582 980__ $$aI:(DE-Juel1)IEK-1-20101013
000055582 980__ $$aI:(DE-82)080011_20140620
000055582 980__ $$aUNRESTRICTED
000055582 981__ $$aI:(DE-Juel1)IMD-2-20101013
000055582 981__ $$aI:(DE-Juel1)IEK-1-20101013
000055582 981__ $$aI:(DE-Juel1)VDB1047